Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
AstraZeneca
Memorial Sloan Kettering Cancer Center
Actuate Therapeutics Inc.
Chang Gung Memorial Hospital
Institut Paoli-Calmettes
AstraZeneca
University College Cork
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of California, San Francisco
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
Novartis
University of Texas Southwestern Medical Center
HistoSonics, Inc.
Merck Sharp & Dohme LLC
Regina Elena Cancer Institute
Medtronic - MITG
AstraZeneca
Vanderbilt University Medical Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Arsenal Biosciences, Inc.
University of Colorado, Denver
University College, London
Sensei Biotherapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of Alabama at Birmingham
University of Chicago
DEKA Biosciences
Merck Sharp & Dohme LLC
Providence Health & Services
Emory University
Merck Sharp & Dohme LLC
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
National Institutes of Health Clinical Center (CC)
Nimbus Therapeutics
Dana-Farber Cancer Institute
Hospital das ClÃnicas de Ribeirão Preto
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Big Ten Cancer Research Consortium